Physician profile
John Melvan
NPI 1205279411
$3,865.49
in general payments reported to CMS, 2019-2025
12 companies · $648 in 2025
The $648 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,503 · 2020: $149 · 2021: $528 · 2022: $843 · 2023: $128 · 2024: $66.12 · 2025: $648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $507 · Travel and Lodging: $335.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $507.04 |
| Travel and Lodging | $335.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,309.25 | 2019 | |
| Edwards Lifesciences Corporation | $988.44 | 2019-2024 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Philips North America LLC | $604.70 | 2025 | Igt Devices Undivided, Fleet Management |
| Endologix LLC | $257.35 | 2020-2021 | |
| Silk Road Medical, INC. | $215.50 | 2022 | |
| Abbott Laboratories | $193.28 | 2021-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Zimmer Biomet Holdings, INC. | $135.08 | 2021 | |
| Ethicon US, LLC | $62.54 | 2022 | |
| Intuitive Surgical, INC. | $34.52 | 2024-2025 | |
| Atricure, INC. | $28.16 | 2025 | Synergy Ablation System |
| Livanova USA, INC. | $19.83 | 2021 | |
| Getinge USA Sales, LLC | $16.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Melvan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.